Literature DB >> 29441216

Cathepsin D Polymorphism C224T in Childhood-Onset Neurodegenerative Disorders: No Impact for Childhood Dementia.

Matthias Kettwig1, Andreas Ohlenbusch1, Klaus Jung2,3, Robert Steinfeld1, Jutta Gärtner1.   

Abstract

Compromised lysosomal functioning has been identified as a major risk factor for neurodegenerative disorders such as Alzheimer's and Parkinson's diseases. Furthermore, the association between a defined cathepsin D ( CTSD ) polymorphism and a higher risk of sporadic Alzheimer's disease has been established for particular populations. Here, we analyzed 189 children with rare neurodegenerative disease for carrying the T-allele by polymerase chain reaction-restriction fragment length polymorphism. We found no statistical differences in genotype and allele frequencies between the neurodegenerative group and European descent participants of genetic studies using the Cochran-Armitage's trend test. In contrast to adult-onset neurodegenerative diseases, analysis of clinical datasets of children carrying the T-allele did not demonstrate differences to the general disease group.

Entities:  

Keywords:  cathepsin D polymorphism; childhood dementia; lysosomal dysfunction; neurodegenerative disorders

Year:  2017        PMID: 29441216      PMCID: PMC5809166          DOI: 10.1055/s-0037-1607341

Source DB:  PubMed          Journal:  J Pediatr Genet        ISSN: 2146-460X


  23 in total

1.  Cathepsin D deficiency is associated with a human neurodegenerative disorder.

Authors:  Robert Steinfeld; Konstanze Reinhardt; Kathrin Schreiber; Merle Hillebrand; Ralph Kraetzner; Wolfgang Bruck; Paul Saftig; Jutta Gartner
Journal:  Am J Hum Genet       Date:  2006-03-29       Impact factor: 11.025

2.  Genetic polymorphism of cathepsin D is strongly associated with the risk for developing sporadic Alzheimer's disease.

Authors:  A Papassotiropoulos; M Bagli; O Feder; F Jessen; W Maier; M L Rao; M Ludwig; S G Schwab; R Heun
Journal:  Neurosci Lett       Date:  1999-03-12       Impact factor: 3.046

3.  A genetic variation of cathepsin D is a major risk factor for Alzheimer's disease.

Authors:  A Papassotiropoulos; M Bagli; A Kurz; J Kornhuber; H Förstl; W Maier; J Pauls; N Lautenschlager; R Heun
Journal:  Ann Neurol       Date:  2000-03       Impact factor: 10.422

4.  The genetic association between Cathepsin D and Alzheimer's disease.

Authors:  F C Crawford; M J Freeman; J Schinka; L I Abdullah; D Richards; S Sevush; R Duara; M J Mullan
Journal:  Neurosci Lett       Date:  2000-07-28       Impact factor: 3.046

5.  Association study of cathepsin D gene polymorphism in Iranian patients with sporadic late-onset Alzheimer's disease.

Authors:  Azadeh Sayad; Mehrdad Noruzinia; Mahdi Zamani; Mohammad Hossein Harirchian; Anoushiravan Kazemnejad
Journal:  Dement Geriatr Cogn Disord       Date:  2013-11-23       Impact factor: 2.959

6.  Presenilin mutations in familial Alzheimer disease and transgenic mouse models accelerate neuronal lysosomal pathology.

Authors:  Anne M Cataldo; Corrinne M Peterhoff; Stephen D Schmidt; Nicole B Terio; Karen Duff; Margaret Beard; Paul M Mathews; Ralph A Nixon
Journal:  J Neuropathol Exp Neurol       Date:  2004-08       Impact factor: 3.685

7.  Missense polymorphism (C/T224) in the human cathepsin D pro-fragment determined by polymerase chain reaction--single strand conformational polymorphism analysis and possible consequences in cancer cells.

Authors:  I Touitou; F Capony; J P Brouillet; H Rochefort
Journal:  Eur J Cancer       Date:  1994       Impact factor: 9.162

8.  Gene expression and cellular content of cathepsin D in Alzheimer's disease brain: evidence for early up-regulation of the endosomal-lysosomal system.

Authors:  A M Cataldo; J L Barnett; S A Berman; J Li; S Quarless; S Bursztajn; C Lippa; R A Nixon
Journal:  Neuron       Date:  1995-03       Impact factor: 17.173

9.  Lysosomal hydrolases of different classes are abnormally distributed in brains of patients with Alzheimer disease.

Authors:  A M Cataldo; P A Paskevich; E Kominami; R A Nixon
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-15       Impact factor: 11.205

10.  Cathepsin D polymorphism in Italian sporadic and familial Alzheimer's disease.

Authors:  Silvia Bagnoli; Benedetta Nacmias; Andrea Tedde; Bianca Maria Guarnieri; Elena Cellini; Monica Ciantelli; Concetta Petruzzi; Antonella Bartoli; Luigi Ortenzi; Antonio Serio; Sandro Sorbi
Journal:  Neurosci Lett       Date:  2002-08-16       Impact factor: 3.046

View more
  2 in total

Review 1.  Cathepsin D-Managing the Delicate Balance.

Authors:  Olja Mijanovic; Anastasiia I Petushkova; Ana Brankovic; Boris Turk; Anna B Solovieva; Angelina I Nikitkina; Sergey Bolevich; Peter S Timashev; Alessandro Parodi; Andrey A Zamyatnin
Journal:  Pharmaceutics       Date:  2021-06-05       Impact factor: 6.321

2.  The c.863A>G (p.Glu288Gly) variant of the CTSD gene is not associated with CLN10 disease.

Authors:  Juan Yang; Xiaoting Ding; Shasha Meng; Jinhua Cai; Weihui Zhou
Journal:  Mol Genet Genomic Med       Date:  2021-07-31       Impact factor: 2.183

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.